Robert Ditmore Biography and Net Worth

Director of Centene


Robert K. Ditmore serves as Presiding Independent Director of the Company. Mr. Ditmore is a retired Director, President and Chief Operating Officer of United Healthcare Corporation (managed care industry), now known as UnitedHealth Group, Inc.

What is Robert K. Ditmore's net worth?

The estimated net worth of Robert K. Ditmore is at least $35.49 million as of July 26th, 2018. Mr. Ditmore owns 472,241 shares of Centene stock worth more than $35,488,911 as of April 20th. This net worth evaluation does not reflect any other assets that Mr. Ditmore may own. Learn More about Robert K. Ditmore's net worth.

How do I contact Robert K. Ditmore?

The corporate mailing address for Mr. Ditmore and other Centene executives is 7700 FORSYTH BOULEVARD, ST LOUIS MO, 63105. Centene can also be reached via phone at (314) 725-4477 and via email at [email protected]. Learn More on Robert K. Ditmore's contact information.

Has Robert K. Ditmore been buying or selling shares of Centene?

Robert K. Ditmore has not been actively trading shares of Centene during the last quarter. Learn More on Robert K. Ditmore's trading history.

Who are Centene's active insiders?

Centene's insider roster includes Andrew Asher (Exec. VP & CFO ), Andrew Asher (CFO), Orlando Ayala (Director), Shannon Bagley (EVP), Mark Brooks (EVP), Kenneth Burdick (EVP), Brandy Burkhalter (COO), Katie Casso (SVP), Robert Ditmore (Director), Kenneth Fasola (President), Richard Gephardt (Director), Jesse Hunter (NASDAQ), Christopher Koster (SVP), Brent Layton (EVP), Sarah London (CEO), Michael Neidorff (CEO), John Roberts (Director), Lori Robinson (Director), Theodore Samuels, II (Director), Jeffrey Schwaneke (CFO), David Thomas (EVP), Tommy Thompson (Director), and Colin Toney (EVP). Learn More on Centene's active insiders.

Are insiders buying or selling shares of Centene?

In the last twelve months, insiders at the sold shares 3 times. They sold a total of 23,400 shares worth more than $1,768,166.00. The most recent insider tranaction occured on February, 13th when Director Lori Jean Robinson sold 10,000 shares worth more than $774,100.00. Insiders at Centene own 0.3% of the company. Learn More about insider trades at Centene.

Information on this page was last updated on 2/13/2024.

Robert K. Ditmore Insider Trading History at Centene

See Full Table

Robert K. Ditmore Buying and Selling Activity at Centene

This chart shows Robert K. Ditmore's buying and selling at Centene by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Centene Company Overview

Centene logo
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.
Read More

Today's Range

Now: $75.15
Low: $73.57
High: $75.35

50 Day Range

MA: $76.56
Low: $70.73
High: $80.41

2 Week Range

Now: $75.15
Low: $60.83
High: $81.42

Volume

2,686,979 shs

Average Volume

3,192,411 shs

Market Capitalization

$40.20 billion

P/E Ratio

15.31

Dividend Yield

N/A

Beta

0.38